Adenovirus 36 Prevalence and Association with Human Obesity: a Systematic Review

Overview

Journal Int J Obes (Lond)

Specialty Endocrinology

Date 2021 Mar 23

PMID 33753885

Citations 9

Authors

Jaime da Silva Fernandes

Fabiana Schuelter-Trevisol

Ana Carolina Lobor Cancelier

Helena Caetano Goncalves E Silva

Daiana Gomes de Sousa

Richard L Atkinson

Daisson Jose Trevisol

Affiliations

Soon will be listed here.

Abstract

Introduction: Obesity has numerous etiologies and includes biological factors. Studies have demonstrated that the human adenovirus subtype 36 (Adv36) is an adipogenic agent and causes metabolic alterations. Study results on the prevalence of Adv36 and clinical effects in humans vary substantially. This was a systematic review to summarize the studies on the prevalence of Adv36 infection and its association with human obesity.

Methods: A systematic literature review was conducted using the preferred reporting items for systematic reviews and meta-analysis (PRISMA). Observational or experimental studies found in the Medline, Embase, LILACS, Science Direct and SciELO databases that presented results on the prevalence of Adv36 in humans were included.

Results: Thirty-seven studies were screened. A total of 10,300 adults aged 18-70 years and 4585 children and adolescents aged 3-18 years were assessed. The average prevalence of Adv36 among adults was 22.9%, ranging from 5.5% to 49.8%. Among children and adolescents, the average prevalence of Adv36 was 28.9%, ranging from 7.5% to 73.9%. There was a positive statistical relationship between Adv36 and weight gain, obesity, or metabolic changes in 31 studies. However, in four studies there was no association with obesity, and in one, no association was described. One of the studies showed an inverse correlation, i.e., Adv36 was a protective factor against obesity.

Conclusion: Strong evidence suggested a positive association between viral infection and obesity. However, due to the multi-causality of obesity and heterogeneity of studies, diagnostic tests should be standardized and easily accessible by the population to estimate the overall prevalence of Adv36 infection and its association with obesity.

Citing Articles

Pan-serological antibodies and liver cancer risk: a nested case-control analysis.

Watling C, Hua X, Petrick J, Zhang X, Do W, Wang L Sci Rep. 2025; 15(1):5450.

PMID: 39953193 PMC: 11828989. DOI: 10.1038/s41598-025-89629-2.

The immunology of sickness metabolism.

Wensveen F, Sestan M, Polic B Cell Mol Immunol. 2024; 21(9):1051-1065.

PMID: 39107476 PMC: 11364700. DOI: 10.1038/s41423-024-01192-4.

Influence of Seropositivity against Adenovirus-36 on the Risk of Obesity and Insulin Resistance in the Child Population of Southern Chile.

Brito R, Sapunar J, Aguilar-Farias N, Navarro-Riquelme J, Pavez M, Hirata M Viruses. 2024; 16(6).

PMID: 38932286 PMC: 11209367. DOI: 10.3390/v16060995.

An Observational Study Suggests That Natural HAdV-36 Infection Decreases Blood Glucose Levels without Affecting Insulin Levels in Obese Young Subjects.

Matia-Garcia I, Ocampo-Galeana J, Munoz-Valle J, Sonanez-Organis J, Gonzalez R, Guzman-Guzman I Viruses. 2024; 16(6).

PMID: 38932214 PMC: 11209432. DOI: 10.3390/v16060922.

What causes obesity in children and adolescents?.

Nogueira-de-Almeida C, Weffort V, da V Ued F, Ferraz I, Contini A, Martinez E J Pediatr (Rio J). 2023; 100 Suppl 1:S48-S56.

PMID: 37918812 PMC: 10960191. DOI: 10.1016/j.jped.2023.09.011.

References

Hruby A, Hu F . The Epidemiology of Obesity: A Big Picture. Pharmacoeconomics. 2014; 33(7):673-89. PMC: 4859313. DOI: 10.1007/s40273-014-0243-x. View

Hainer V, Zamrazilova H, Kunesova M, Bendlova B, Aldhoon-Hainerova I . Obesity and infection: reciprocal causality. Physiol Res. 2015; 64(Suppl 2):S105-19. DOI: 10.33549/physiolres.933130. View

Mullen J, Moorman D, Davenport D . The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg. 2009; 250(1):166-72. DOI: 10.1097/SLA.0b013e3181ad8935. View

Morgan O, Bramley A, Fowlkes A, Freedman D, Taylor T, Gargiullo P . Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One. 2010; 5(3):e9694. PMC: 2837749. DOI: 10.1371/journal.pone.0009694. View

Arslan E, Atilgan H, Yavasoglu I . The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med. 2009; 20(7):695-7. DOI: 10.1016/j.ejim.2009.07.013. View

Uberos J, Molina-Carballo A, Fernandez-Puentes V, Rodriguez-Belmonte R, Munoz-Hoyos A . Overweight and obesity as risk factors for the asymptomatic carrier state of Neisseria meningitidis among a paediatric population. Eur J Clin Microbiol Infect Dis. 2010; 29(3):333-4. DOI: 10.1007/s10096-009-0849-7. View

Nadeau K, Maahs D, Daniels S, Eckel R . Childhood obesity and cardiovascular disease: links and prevention strategies. Nat Rev Cardiol. 2011; 8(9):513-25. PMC: 4292916. DOI: 10.1038/nrcardio.2011.86. View

Jubber A . Respiratory complications of obesity. Int J Clin Pract. 2004; 58(6):573-80. DOI: 10.1111/j.1368-5031.2004.00166.x. View

Roswall N, Li Y, Sandin S, Strom P, Adami H, Weiderpass E . Changes in body mass index and waist circumference and concurrent mortality among Swedish women. Obesity (Silver Spring). 2016; 25(1):215-222. DOI: 10.1002/oby.21675. View

10.

Hill J, Wyatt H, Melanson E . Genetic and environmental contributions to obesity. Med Clin North Am. 2000; 84(2):333-46. DOI: 10.1016/s0025-7125(05)70224-8. View

11.

Zhang Y, Liu J, Yao J, Ji G, Qian L, Wang J . Obesity: pathophysiology and intervention. Nutrients. 2014; 6(11):5153-83. PMC: 4245585. DOI: 10.3390/nu6115153. View

12.

English W, Williams D . Metabolic and Bariatric Surgery: An Effective Treatment Option for Obesity and Cardiovascular Disease. Prog Cardiovasc Dis. 2018; 61(2):253-269. DOI: 10.1016/j.pcad.2018.06.003. View

13.

Manna P, Jain S . Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies. Metab Syndr Relat Disord. 2015; 13(10):423-44. PMC: 4808277. DOI: 10.1089/met.2015.0095. View

14.

Dhurandhar N . Is obesity caused by an adenovirus?. Expert Rev Anti Infect Ther. 2012; 10(5):521-4. DOI: 10.1586/eri.12.41. View

15.

Kim J, van de Wall E, Laplante M, Azzara A, Trujillo M, Hofmann S . Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest. 2007; 117(9):2621-37. PMC: 1950456. DOI: 10.1172/JCI31021. View

16.

Lyons M, Faust I, Hemmes R, Buskirk D, Hirsch J, Zabriskie J . A virally induced obesity syndrome in mice. Science. 1982; 216(4541):82-5. DOI: 10.1126/science.7038878. View

17.

Verlaeten O, Griffond B, Khuth S, Giraudon P, Akaoka H, Belin M . Down regulation of melanin concentrating hormone in virally induced obesity. Mol Cell Endocrinol. 2001; 181(1-2):207-19. DOI: 10.1016/s0303-7207(01)00488-9. View

18.

Herden C, Herzog S, Richt J, Nesseler A, Christ M, Failing K . Distribution of Borna disease virus in the brain of rats infected with an obesity-inducing virus strain. Brain Pathol. 2000; 10(1):39-48. PMC: 8098463. DOI: 10.1111/j.1750-3639.2000.tb00241.x. View

19.

Pasarica M, Shin A, Yu M, Ou Yang H, Rathod M, Jen K . Human adenovirus 36 induces adiposity, increases insulin sensitivity, and alters hypothalamic monoamines in rats. Obesity (Silver Spring). 2006; 14(11):1905-13. DOI: 10.1038/oby.2006.222. View

20.

Dhurandhar N, Kulkarni P, Ajinkya S, Sherikar A . Effect of adenovirus infection on adiposity in chicken. Vet Microbiol. 1992; 31(2-3):101-7. DOI: 10.1016/0378-1135(92)90068-5. View